• Abbvie Inc.: HSBC upgrades to buy from hold and raises the target price from USD 225 to USD 265.
  • Biogen Inc.: HSBC downgrades to reduce from hold and reduces the target price from USD 144 to USD 143.
  • Blue Owl Capital Inc.: Raymond James upgrades to strong buy from market perform with a target price of USD 20.
  • Commercial Metals Company: Jefferies upgrades to buy from hold and raises the target price from USD 70 to USD 78.
  • Confluent, Inc.: Guggenheim downgrades to neutral from buy.
  • Echostar Corporation: Morgan Stanley upgrades to overweight from equalwt and raises the target price from USD 82 to USD 110.
  • Emerson Electric Co.: Jefferies downgrades to hold from buy with a target price of USD 145.
  • Ge Vernova Inc.: BM Pekao upgrades to hold from sell with a price target raised from USD 505 to USD 637.
  • Pentair Plc: Jefferies upgrades to buy from hold and raises the target price from USD 120 to USD 135.
  • Pepsico, Inc.: JP Morgan upgrades to overweight from neutral with a price target raised from USD 151 to USD 164.
  • Veralto Corporation: Jefferies downgrades to hold from buy and reduces the target price from USD 125 to USD 105.
  • Eli Lilly And Company: HSBC maintains its hold recommendation and raises the target price from USD 850 to USD 1070.
  • Exxon Mobil Corporation: Evercore ISI maintains its outperform recommendation and raises the target price from USD 120 to USD 145.
  • Gilead Sciences, Inc.: HSBC maintains its hold recommendation and raises the target price from USD 110 to USD 133.
  • Jazz Pharmaceuticals Plc: Piper Sandler & Co maintains its overweight recommendation and raises the target price from USD 147 to USD 219.
  • Netflix, Inc.: CICC maintains its outperform recommendation and reduces the target price from USD 1350 to USD 120.
  • Newmont Corporation: RBC Capital maintains its outperform recommendation and raises the target price from USD 97 to USD 120.